ALPS Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
|
|||||
|
2025
Q1 | $1.86M | Sell |
|
|||||
|
2024
Q4 | $2.42M | Buy |
|
|||||
|
2024
Q3 | $2.24M | Sell |
|
|||||
|
2024
Q2 | $2.29M | Buy |
|
|||||
|
2024
Q1 | $2.29M | Buy |
|
|||||
|
2023
Q4 | $2.34M | Buy |
|
|||||
|
2023
Q3 | $1.62M | Buy |
|
|||||
|
2023
Q2 | $1.8M | Buy |
|
|||||
|
2023
Q1 | $1.49M | Sell |
|
|||||
|
2022
Q4 | $1.67M | Buy |
|
|||||
|
2022
Q3 | $1.23M | Buy |
|
|||||
|
2022
Q2 | $958K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.86M | Buy |
|
|||||
|
2021
Q3 | $770K | Sell |
|
|||||
|
2021
Q2 | $1M | Sell |
|
|||||
|
2021
Q1 | $1.13M | Buy |
|
|||||
|
2020
Q4 | $973K | Buy |
|
|||||
|
2020
Q3 | $494K | Sell |
|
|||||
|
2020
Q2 | $598K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $463K | Sell |
|
|||||
|
2019
Q2 | $531K | Sell |
|
|||||
|
2019
Q1 | $619K | Buy |
|
|||||
|
2018
Q4 | $365K | Buy |
|